A new diagnostic perspective – hyperglycemia in pregnancy – as of the year, 2014

• Authors: Katarzyna Strawa-Zakoscielna , Monika Lenart-Lipinska , Aneta Szafraniec , Grzegorz Rudzki , Beata Matyjaszek-Matuszek
• Languages of publication: EN

Abstracts

EN

Gestational Diabetes Mellitus (GDM) is a growing epidemiological problem, and it is currently the most common metabolic disorder in pregnancy, as it affects approximately 2-6% of all pregnant women. In 2014, the Polish Diabetic Association introduced significant changes in the diagnosis of hyperglycemia as first diagnosed in pregnancy, based on the recommendations of the IADPSG of 2010 and WHO of 2013. There are now two categories: diabetes in pregnancy, and GDM. These involve different degrees of severity of metabolic complications for the mother and the growing fetus. Establishing a new diagnostic criterion is significant because of the negative impact of hyperglycemia on the fetus (especially in the first trimester), the increased prevalence of malformations or the possibility of spontaneous abortions in early pregnancy.

Keywords

EN

Gestational Diabetes Mellitus; GDM; diabetes in pregnancy

• Publisher: De Gruyter Open
• Journal: Current Issues in Pharmacy and Medical Sciences
• Year: 2014
• Volume: 27
• Issue: 4
• Pages: 246-249

Dates

published

1 - 12 - 2014

accepted

15 - 12 - 2014

online

3 - 3 - 2015

received

5 - 12 - 2014

Contributors

author

Katarzyna Strawa-Zakoscielna

• Department of Endocrinology, Medical University of Lublin, Jaczewskiego 8, Lublin, Poland

author

Monika Lenart-Lipinska

• Department of Laboratory Diagnostics, Medical University of Lublin, Chodzki 1, Lublin, Poland

author

Aneta Szafraniec

• Department of Endocrinology, Medical University of Lublin, Jaczewskiego 8, Lublin, Poland

author

Grzegorz Rudzki

• Department of Endocrinology, Medical University of Lublin, Jaczewskiego 8, Lublin, Poland

author

Beata Matyjaszek-Matuszek

• Department of Endocrinology, Medical University of Lublin, Jaczewskiego 8, Lublin, Poland

References

• 1. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care, 2014 Jan; 37 Suppl 1: 81-90.[Crossref]
• 2. Barbour L.A. et al.: Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care, 30, 112-19, 2007.[WoS]
• 3. Ben-Haroush A., Yogev Y., Hod M.: Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet Med, 21[2], 103-13, 2004.[Crossref]
• 4. Briana D.D., Malamitsi-Puchner A.: Reviews: adipocytokines in normal and complicated pregnancies. Reprod Sci, 16 (10), 921-37, 2009.[Crossref]
• 5. Buchanan T.A. et al.: What is gestational diabetes? Diabetes Care, 30, 105-11, 2007.
• 6. Cypryk K., Wender-Ożegowska E.: Ciąża powikłana cukrzycą. W: Moczulski D. (red.) Diabetologia. Medical Tribune Polska. Warszawa 2010; 108-118. ISBN 978-83-60135-85-3.
• 7. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. Diabetes Res Clin Pract. 2014.[WoS][PubMed]
• 8. Ferrara A. et al.: Prevalence of gestational diabetes mellitus detected by the national diabetes data group or the Carpenter and Coustan plasma glucose thresholds. Diabetes Care, 25 (9), 1625-30, 2002.[Crossref]
• 9. Galtier F.: Definition, epidemiology, risk factors. Diabetes Metab, 36, 628-51, 2010.[WoS]
• 10. Hayes C.: Long-term prognostic factors in the diagnosis of gestational diabetes. Br J Nurs, 18(9), 523-34, 2009.[Crossref]
• 11. Jovanovic L., Pettitt D.J.: Gestational diabetes mellitus. JAMA, 286(20), 2516-18, 2001.
• 12. Karagiannis T. et al.: Gestational diabetes mellitus: why screen and how to diagnose. Hippokratia, 14[3], 151-4, 2010.
• 13. Metzger B.E. et al.: Hyperglycemia and adverse pregnancy outcomes. HAPO Study Cooperative Research Group, N Engl J Med, 358 (19), 1991-2002, 2008.
• 14. Metzger B.E. et al.: International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care, 33[3], 676-82, 2010.[WoS][Crossref]
• 15. Retnakaran R. et al.: Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications. Diabetologia, 48 (5), 993-1001, 2005.[Crossref]
• 16. Retnakaran R. et al.: Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care, 27, 799-800, 2004.
• 17. Schäfer-Graf U.M. et al.: Diagnostik und Therapie des Gestationsdiabetes (GDM) [online]. W: Deutsche Gesellschaft für Gynäkologie und Geburtshilfe e.V. Dostępny w World Wide Web: http://www.dggg.de/fileadmin/public_docs/Leitlinien/3-3-3-gestationsdiabetes-2010.pdf.
• 18. Valsamakis G. et al.: The effects of adipose tissue and adipocytokines in human pregnancy. Ann N Y Acad Sci, 1205, 76-81, 2010.
• 19. Wójcikowski C. et al.: The prevalence of gestational diabetes mellitus in the Polish population. Ginekol Pol, 73 (10), 811-16, 2002.
• 20. Zalecenia kliniczne dotyczące postępowania u chorych na cukrzycę 2014. Stanowisko Polskiego Towarzystwa Diabetologicznego. Diabetol Klin, 3, supl A, 46-9, 2014.

Identifiers

DOI

10.1515/cipms-2015-0026